Global Sodium 4-Aminosalicylate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sodium 4-Aminosalicylate Market Research Report 2024
Sodium p-aminosalicylate is indicated for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. Intravenous infusion can be used to treat tuberculous meningitis and acute diffuse tuberculosis. This product is only effective against mycobacteria. Mycobacterium tuberculosis can rapidly develop drug resistance when used alone, so this product must be used in combination with other anti-tuberculosis drugs.
According to Mr Accuracy reports’s new survey, global Sodium 4-Aminosalicylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium 4-Aminosalicylate market research.
Tuberculosis is one of the major challenges to global public health and the second leading cause of death from a single source of infection in the world after 2019-nCoV infection. According to the World Health Organization (WHO) report, in 2020, it is estimated that there will be 9.9 million new tuberculosis patients in the world, the incidence rate of tuberculosis is 127/100,000, and about 1.3 million deaths. Sodium p-aminosalicylate is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. The increase in tuberculosis patients will gradually increase the sodium para-aminosalicylate market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium 4-Aminosalicylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Jacobus Pharmaceutical Co Inc
Eurocept International bv
Harbin Pharmaceutical Group
HUAPONT PHARM
Zhendong group
KAIFENG PHARMACEUTICAL (GROUP) CO.,LTD
Segment by Type
Injection
Particles
Hospital
Specialist Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium 4-Aminosalicylate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Sodium 4-Aminosalicylate market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium 4-Aminosalicylate market research.
Tuberculosis is one of the major challenges to global public health and the second leading cause of death from a single source of infection in the world after 2019-nCoV infection. According to the World Health Organization (WHO) report, in 2020, it is estimated that there will be 9.9 million new tuberculosis patients in the world, the incidence rate of tuberculosis is 127/100,000, and about 1.3 million deaths. Sodium p-aminosalicylate is suitable for pulmonary and extrapulmonary tuberculosis caused by Mycobacterium tuberculosis. The increase in tuberculosis patients will gradually increase the sodium para-aminosalicylate market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sodium 4-Aminosalicylate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Jacobus Pharmaceutical Co Inc
Eurocept International bv
Harbin Pharmaceutical Group
HUAPONT PHARM
Zhendong group
KAIFENG PHARMACEUTICAL (GROUP) CO.,LTD
Segment by Type
Injection
Particles
Segment by Application
Hospital
Specialist Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium 4-Aminosalicylate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
